Filing Details

Accession Number:
0001144204-14-042002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-08 21:00:44
Reporting Period:
2014-07-03
Filing Date:
2014-07-08
Accepted Time:
2014-07-08 21:00:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571320 Paul Daniel Regan C/O Intercept Pharmaceuticals, Inc.
450 W. 15Th Street, Suite 505
New York NY 10011
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-03 1 $37.69 1,411 No 4 M Direct
Common Stock Disposition 2014-07-03 1 $250.00 1,410 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2014-07-03 1 $0.00 1 $37.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
109,999 2023-03-04 No 4 M Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2014.
  2. The remaining shares underlying this option vest on a pro rata monthly basis through March 4, 2017, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan.